In the highly-regulated life sciences industry, facing potentially decade-long product lifecycles, steep investments and competition limited by patents, the speed and cost performance of supply chains has been somewhat masked. But now, market forces are combining with an influx of product and business model innovations to create a new dawn for global supply chain leaders.
This paper describes how life sciences global supply chain executives can strengthen their operational capabilities to support strategic cost, adaptability, and speed goals:
Lower global logistics costs
Improved control and visibility across supply chain and production
Reduced risks, errors, and delays to improve time-to-market
Reduced risk of regulatory non-compliance